Friday, August 17, 2012

In the USA allowed application of the digital microtablet IEM



В США разрешено применение цифровой микротаблеткиManagement on quality control of products and drugs of the USA (Food and Drug Administration, FDA) approved application in medical practice in the territory of the country of a so-called digital microtablet - the tiny touch sensor which after hit to the gastroenteric highway of the person can hand over information on a state of his health on various digital devices.
В США разрешено применение цифровой микротаблеткиIngestion Event Marker (IEM) in August, 2010 was resolved to use in the territory of the European Union and is the first similar development which has obtained permit of FDA.
The having size of a grain of sand of IEM doesn't contain a battery and represents a silicon chip with the provodnikovy materials fixed on both parties, placed in a soluble cover. Getting after a proglatyvaniye to a stomach, the sensor on a small interval of time is activated under the influence of sour gastric juice and starts to transmit a signal on the microchip of the bigger size attached to skin by means of a plaster.
This microchip, in turn, fixes time of receiving a signal from IEM and relays it or on the computer or the mobile phone of the attending physician or the trustee of the patient, or on the electronic device belonging to the patient. After IEM, having passed through ZhKT, will execute the function, it is deduced from an organism in the regular way.
As the company developer of the device which is based in California by Proteus Digital Health declares, IEM can be applied to remote control of timely and correct reception by patients of the appointed drugs that is especially important during clinical tests of various preparations. It is supposed that the patient should swallow such sensor at the same time with medicine then the doctor or the trustee of the patient receives information on time of reception and quantity of the accepted preparation. Producers of IEM hope that in the future the pharmaceutical companies will include it in structure of drugs directly in the course of their production.
Besides information on drug intake, note in Proteus Digital Health, by means of IEM it is possible to receive far off also data on work of different systems of an organism of the patient that allows the doctor to have a constant and a full picture of the events.

No comments:

Post a Comment